We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Bristol Myers Squibb Co | NYSE:BMY | NYSE | Common Stock |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| -0.94 | -1.92% | 47.92 | 160,311 | 13:29:21 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 45.01B | 8.03B | 3.9685 | 12.31 | 98.8B |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 13:29:18 | formt | 1,600 | 47.92 | USD |
| Date | Time | Source | Headline |
|---|---|---|---|
| 08/1/2024 | 16:46 | DJN | Bristol Myers Reaffirms Long-Term Financial Targets |
| 02/1/2024 | 16:28 | DJN | Bristol-Myers Squibb on Pace for Largest Percent Increase Since December.. |
| 26/12/2023 | 15:28 | DJN | Trending: Bristol Myers Squibb to Buy RayzeBio |
| 26/12/2023 | 13:04 | DJN | RayzeBio Shares Soar Premarket on Takeover by Bristol Myers |
| 26/12/2023 | 12:46 | DJN | Bristol Myers Squibb to Buy RayzeBio for $4.1 Billion |
| 22/12/2023 | 16:15 | DJN | Trending: Bristol Myers to Buy Karuna Therapeutics for $14 Billion |
| 15/12/2023 | 22:40 | DJN | Bristol Myers Squibb to Discontinue Metastatic Colorectal Cancer Trial |
| 07/12/2023 | 12:11 | DJN | Bristol Myers Adds $3 Billion to Stock Buyback Program |
| 06/12/2023 | 22:07 | DJN | Bristol Myers Squibb Raises Dividend 5.3%, to 60 Cents |
| 05/12/2023 | 12:55 | DJN | Bristol Myers Gets FDA Priority Review of Opdivo-Chemotherapy Combo in.. |
Bristol Myers Squibb (BMY) Share Charts1 Year Bristol Myers Squibb Chart |
|
1 Month Bristol Myers Squibb Chart |
Intraday Bristol Myers Squibb Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
